Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	185.38	340.65	320.7	321.71	94.58
Short-Term Investments	410.27	270.33	85.1	6.68	0
Cash & Cash Equivalents	595.65	610.98	405.79	328.39	94.58
Cash Growth	-2.51%	50.56%	23.57%	247.22%	2960.78%
Other Current Assets	15.66	11.96	5.35	3.29	1.1
Total Current Assets	611.31	622.94	411.14	331.68	95.68
Property, Plant & Equipment	16.65	15.01	15.59	1.92	0.63
Other Long-Term Assets	0.6	0.85	0.85	0.3	0.6
Total Long-Term Assets	17.25	15.86	16.44	2.22	1.23
Total Assets	628.56	638.8	427.58	333.9	96.91
Accounts Payable	34.34	32.57	14.09	7.75	2.31
Deferred Revenue	69.26	6.28	11.4	15.84	18.94
Current Debt	3.64	3.11	1.77	0	2.77
Other Current Liabilities	-26.56	9.96	2.41	-9	-13.79
Total Current Liabilities	80.68	51.91	29.66	14.59	10.24
Long-Term Debt	6.21	7.58	9.96	0.94	2.16
Other Long-Term Liabilities	40.9	1.24	6.53	12.15	15.15
Total Long-Term Liabilities	47.11	8.82	16.49	13.09	17.31
Total Liabilities	127.79	60.73	46.15	27.68	27.54
Total Debt	9.85	10.69	11.73	0.94	4.94
Debt Growth	-7.81%	-8.88%	1150.43%	-81.00%	-52.18%
Retained Earnings	-570.76	-358.54	-184.55	-66.54	-22.19
Comprehensive Income	0.13	-2.7	-0.19	-0.01	0
Shareholders' Equity	500.76	578.08	381.43	306.22	-65.36
Net Cash / Debt	585.79	600.29	394.07	327.45	89.64
Net Cash / Debt Growth	-2.41%	52.33%	20.34%	265.29%	-
Net Cash Per Share	8.02	11.51	9.51	15.12	33.04
Working Capital	530.63	571.03	381.48	317.09	85.44
Book Value Per Share	6.86	11.08	9.21	14.14	-24.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).